v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (6,266,000) $ (4,385,000) $ (4,458,000) $ 2,599,000 $ (10,651,000) $ (1,859,000) $ (2,300,000)
Adjustments to reconcile net income to cash used in operating activities:              
Change in fair value of common stock warrant and option liabilities (3,083,000)   548,000   (4,274,000) (1,314,000)  
Change in fair value of contingent consideration         0 (2,000,000)  
Issuance and offering costs 651,000   0   1,072,000 0  
Valuation loss on June 2026 PIPE 5,423,000   0   5,423,000 0  
Loss on January 2026 Inducement Offer 0   0   2,877,000 0  
Depreciation 0   15,000   8,000 28,000  
Lease amortization         0 117,000  
Amortization of note receivable         0 (69,000)  
Gain on sale of intangible assets 0   0   0 (750,000)  
Gain on receipt of Above Food Ingredients, Inc. common stock         0 (1,067,000)  
Unrealized loss subsequent to receipt of Above Food Ingredients, Inc. common stock         4,304,000 0  
Stock-based compensation 14,000   86,000   29,000 164,000  
Credit loss 0   4,489,000   0 4,489,000  
Changes in operating assets and liabilities:              
Accounts receivable and other receivables         (134,000) (417,000)  
Inventories         282,000 (585,000)  
Prepaid expenses and other current assets         84,000 544,000  
Other noncurrent assets         0 (56,000)  
Accounts payable and accrued expenses         (431,000) (630,000)  
Amounts due to related parties         0 (30,000)  
Other current liabilities         (7,000) (57,000)  
Operating lease liabilities         0 (129,000)  
Net cash used in operating activities         (1,418,000) (3,621,000) (4,700,000)
CASH FLOWS FROM INVESTING ACTIVITIES:              
Proceeds from sale of intangible assets         0 750,000  
Net cash provided by investing activities         0 750,000  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from ESPP purchases         0 5,000  
Net cash provided by financing activities         5,337,000 5,000  
Net increase (decrease) in cash and cash equivalents         3,919,000 (2,866,000)  
Cash and cash equivalents - beginning of period   $ 259,000   $ 4,242,000 259,000 4,242,000 4,242,000
Cash and cash equivalents - end of period $ 4,178,000   $ 1,376,000   4,178,000 1,376,000 $ 259,000
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Fair value of Above Food Ingredients, Inc. common stock received         0 3,067,000  
January 2026 Inducement Offer [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from January 2026 Inducement Offer         2,082,000 0  
Payments of offering costs         (350,000) 0  
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Preferred investment options issued to placement agent and included in offering costs         71,000 0  
Warrant and option modifications included in Loss on January 2026 Inducement Offer         555,000 0  
June 2026 PIPE [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from June 2026 PIPE         4,000,000 0  
Payments of offering costs         (395,000) 0  
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Accrued legal fees included in offering costs         55,000 0  
Preferred investment options issued to placement agent and included in offering costs         $ 201,000 $ 0